Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CFO resigned
Acq. announced
CC transcript
Director departure
|
|
AVANIR PHARMACEUTICALS, INC. (AVNR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2015 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 0% stake in AVANIR PHARMACEUTICALS INC |
| 02/09/2015 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 12.1% stake in AVANIR PHARMACEUTICALS INC |
| 01/26/2015 |
SC 13G/A
| BlackRock Inc. reports a 7.5% stake in AVANIR PHARMACEUTICALS INC |
| 01/12/2015 |
SC 13G/A
| FMR LLC reports a 2.4% stake in AVANIR PHARMACEUTICALS |
| 11/10/2014 |
SC 13G/A
| BAKER BROS. ADVISORS LP reports a 17% stake in Avanir Pharmaceuticals, Inc. |
| 11/10/2014 |
SC 13G/A
| FMR LLC reports a 10.8% stake in AVANIR PHARMACEUTICALS |
| 09/12/2014 |
SC 13G/A
| INGALLS & SNYDER LLC reports a 3.8% stake in AVANIR PHARMACEUTICALS, INC. |
| 02/14/2014 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 1.9% stake in Avanir Pharmaceuticals, Inc. |
| 02/14/2014 |
SC 13G/A
| FMR LLC reports a 5.8% stake in AVANIR PHARMACEUTICALS |
| 02/11/2014 |
SC 13G/A
| VANGUARD GROUP INC reports a 2.8% stake in AVANIR Pharmaceuticals Inc |
| 02/10/2014 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 16.3% stake in AVANIR PHARMACEUTICALS INC |
| 02/07/2014 |
SC 13G/A
| INGALLS & SNYDER LLC reports a 7.3% stake in AVANIR PHARMACEUTICALS, INC. |
| 01/28/2014 |
SC 13G/A
| BlackRock Inc. reports a 7.9% stake in AVANIR PHARMACEUTICALS INC. CL A |
| 02/14/2013 |
SC 13G/A
| FMR LLC reports a 10.5% stake in AVANIR PHARMACEUTICALS |
| 02/06/2013 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 15.9% stake in AVANIR PHARMACEUTICALS INC |
| 02/06/2013 |
SC 13G/A
| BlackRock Inc. reports a 6.3% stake in AVANIR PHARMACEUTICALS INC. CL A |
| 01/28/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/12/2012 |
SC 13G/A
| FMR LLC reports a 10.3% stake in AVANIR PHARMACEUTICALS |
| 02/08/2012 |
SC 13G/A
| AVANIR PHARMACEUTICALS, INC. reports a 15.4% stake in AVANIR PHARMACEUTICALS INC |
| 02/07/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/17/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| AVANIR PHARMACEUTICALS, INC. reports a 2.5% stake in AVANIR PHARMACEUTICALS, INC. |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| ProQuest Investments III, L.P. reports a 0% stake in Avanir Pharmaceuticals |
| 01/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2010 |
SC 13G/A
| Vivo Ventures Fund VI, L.P. reports a 9.6% stake in AVANIR PHARMACEUTICALS, INC. |
| 02/09/2010 |
SC 13G/A
| ProQuest Investments III, L.P. reports a 11.5% stake in Avanir Pharmaceuticals |
| 02/12/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 08/07/2008 |
SC 13G/A
| ProQuest Investments IV, L.P. reports a 13% stake in 1 Avanir Pharmaceuticals |
| 02/14/2008 |
SC 13G/A
| Ridgeback Capital Investments L.P. reports a 0% stake in 1 AVANIR PHARMACEUTICALS |
| 01/31/2007 |
SC 13G/A
| J P MORGAN CHASE & CO reports a 3.5% stake in AVANIR PHARMACEUTICALS |
| 02/08/2006 |
SC 13G/A
| J P MORGAN CHASE & CO reports a 6.4% stake in AVANIR PHARMACEUTICALS |
|
|